Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME program

PURPOSE: Among metastatic breast cancer (MBC) patients, those with a triple-negative breast cancer phenotype (mTNBC) have the worst prognosis, but the benefit of chemotherapy beyond second line on outcome remains uncertain. The purpose of this study was to identify predictive factors of outcome afte...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast
Main Authors: Cabel, Luc, Carton, Matthieu, Pistilli, Barbara, Dalenc, Florence, Vanlemnens, Laurence, Levy, Christelle, Jacot, William, Debled, Michel, Loeb, Agnes, Hennequin, Audrey, De la Motte Rouge, Thibault, Laborde, Lilian, Laurent, Carine, Chamorey, E., Parent, Damien, Petit, Thierry, Mouret-Reynier, Marie-Ange, Campone, Mario, Perrocheau, Geneviève, Labreveux, Claire, Bachelot, Thomas, Robain, Mathieu, Lerebours, Florence
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7873471/
https://ncbi.nlm.nih.gov/pubmed/33561617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2021.01.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados